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Abstract 
A new and rapid high-performance thin-layer chromatographic (HPTLC) method was developed and 
validated for quantitative determination of Bamifylline. The HPTLC separation was achieved on an aluminum-
backed layer of silica gel 60F254 using methanol: toluene (2.5 + 7.5 v/v) as mobile phase. Quantitation was 
achieved by densitometric analysis at 277 nm over the concentration range of 100–600 ng/spot. The method 
was found to give compact spot for the drug (Rf = 0.51 ± 0.01). The linear regression analysis data for the 
calibration plots showed good linear relationship with r2 = 0.9995. The method was validated for precision, 
recovery, repeatability, and robustness as per the International Conference on Harmonization guidelines. The 
minimum detectable amount was found to be 7.65 ng/spot, whereas the limit of quantitation was found to be 
23.19 ng/spot. Statistical analysis of the data showed that the method is precise, accurate, reproducible, 
sensitive and selective for the analysis of Bamifylline. The method was successfully employed for the 
estimation of Bamifylline as a bulk drug and in commercially available tablet formulation. 
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1. Introduction 
Bamifylline, a xanthine derivative with 
bronchodilator properties, is used in the treatment of 
asthma and reversible airway obstructions. The 
physico-chemical and pharmacokinetic properties of 
bamifylline differ from those of theophylline. 
Chemically Bamifylline is 8-benzyl-7-[2-[ethyl (2-
hydroxyethyl) amino] ethyl]-1, 3-dimethylpurine-2,6-
dione1.  
No official method for the estimation of 
Bamifylline is available in literature. Papadoyannis et 
al., reported simultaneous determination of 
Bamifylline and its major metabolite by RP-HPLC in 
tablets and suppositories1. Gerlo et al., reported 
HPLC method for assay of Bamifylline in human 
plasma of Neonates2. Belliardo et al., HPLC method 
for determination of bamifylline and its major 
metabolite in human plasma3. Nicot et al., reported 
HPLC method for Determination of bamifylline and 
its three major metabolite in human plasma4. Carlucci 
et al., reported determination of bamifylline 
hydrochloride impurities in bulk material and 
pharmaceutical forms using liquid chromatography 
with ultraviolet detection5.  
Most of the methods reported were intended 
for the analysis of biological samples and require 
tedious procedures for sample pretreatment. The 
HPLC technique is excellent with respect to 
selectivity and sensitivity, but it cannot be used for 
routine analysis because of their speciality 
requirement and cost. Consequently, high-
performance thin layer chromatography (HPTLC) 
based methods could be considered as a good 
alternative as they are being explored as an important 
tool in routine drug analysis. Major advantage of 
HPTLC is its ability to analyze several samples 
simultaneously using a small quantity of mobile 
phase. This reduces time and cost of analysis. In 
addition, it minimizes exposure risks and 
significantly reduces disposal problems of toxic 
organic effluents, thereby reducing possibilities of 
environment pollution. HPTLC also facilitates 
repeated detection of chromatogram with same or 
different parameters. Furthermore, in case of HPTLC, 
there are no restrictions on the choice of solvents and 
mobile phases; drug and excipients can be dissolved 
in a suitable solvent that would evaporate during 
spotting on TLC plate leaving behind analyte as a 
thin band6. Therefore, for such methods, extraction 
procedure is not required always and could be 
developed for analyzing drug without any 
interference from excipients. Because of the absence 
of an official pharmacopoeial method for the 
determination of Bamifylline in pharmaceutical 
formulations and nonappearance of HPTLC method 
in literature, efforts were made to develop an 
analytical method for the estimation of Bamifylline in 
pharmaceutical dosage form using HPTLC methods. 
The present study describes the development and 
validation of HPTLC method for routine estimation 
of Bamifylline from bulk and pharmaceutical dosage 
forms such as tablets. 
2. Materials and Methods 
2.1. Apparatus 
The HPTLC system (Camag, Muttenz, 
Switzerland) consisted of Limomat V autosprayer 
connected to a nitrogen cylinder, a twin trough 
chamber (10 × 10 cm), a derivatization chamber, and 
a plate heater. Pre-coated silica gel 60 F254 HPTLC 
plates (10 × 10 cm, layer thickness 0.2 mm (E. Merck 
KGaA, Darmstadt, Germany) was used as stationary 
phase. HPTLC plates were pre-washed twice with 10 
Research Article                                                                                             Patel et al /2012 
 
84 
 
mL of methanol and activated at 80°C for 5 min prior 
to sample application. Densitometric analysis was 
carried out using a TLC scanner III with winCATS 
software. 
2.2. Reagents and materials 
The pure Bamifylline powder was obtained 
from Cadila Healthcare Ltd., (India) with 99.9 % 
purity. Methanol, chloroform, toluene and ammonia 
were purchased from SDfine Chemicals 
(Ahmedabad, India). All other chemicals and 
solvents were of analytical reagent grade and used as 
received without further purification. 
2.3. HPTLC method and chromatographic 
conditions 
2.3.1. Sample application 
The standard and formulation samples of 
Bamifylline were spotted on pre-coated HPTLC 
plates in the form of narrow bands of lengths 6 mm, 
with 10 mm from the bottom and left margin and 
with 9 mm distance between two bands. Samples 
were applied under continuous drying stream of 
nitrogen gas at constant application rate of 150 nL/s. 
2.3.2. Mobile phase and migration 
Plates were developed using mobile phase 
consisting of methanol: toluene (2.5+ 7.5 v/v). Linear 
ascending development was carried out in 10 cm × 10 
cm twin trough glass chamber equilibrated with 
mobile phase. The optimized chamber saturation time 
for mobile phase was 20 min at 25 ± 2°C. Ten 
milliliters of the mobile phase (5 mL in trough 
containing the plate and 5 mL in other trough) was 
used for each development and allowed to migrate a 
distance of 70 mm, which required 10 min. After 
development, the HPTLC plates were dried 
completely. 
2.3.3. Densitometric analysis and quantitation 
procedure 
Densitometric scanning was performed on 
Camag TLC scanner III in absorbance mode and 
operated by winCATS planar chromatography 
version 1.3.4. The source of radiation utilized was 
deuterium lamp. The spots were analyzed at a 
wavelength of 277 nm. The slit dimensions used in 
the analysis were length and width of 5 mm and 0.45 
mm, respectively, with a scanning rate of 20 mm/s. 
These are selected as recommended by the CAMAG 
TLC Scanner III manual. It covers 70–90% of the 
application band length, which in the present case is 
6 mm. The monochromator bandwidth was set at 20 
nm. Concentrations of compound chromatographed 
were determined from the intensity of diffusely 
reflected light and evaluated as peak areas against 
concentrations using linear regression equation. 
2.3.4. Preparation of Bamifylline standard stock 
solution 
Stock solution was prepared by weighing 
Bamifylline (10 mg). Weighed powder was 
accurately transferred to a volumetric flask of 100 
mL and dissolved in and diluted to the mark with 
methanol to obtain a standard stock solution of 
Bamifylline (100 µg/mL). 
2.4. Method validation 
Validation of the developed HPTLC method 
was carried out as per the International Conference 
on Harmonization (ICH) guidelines Q2 (R1) for 
specificity, sensitivity, accuracy, precision, 
repeatability, and robustness. 
2.4.1. Specificity 
The specificity of the developed method was 
established analyzing the sample solutions containing 
Bamifylline in marketed tablets in relation to 
interferences from formulation ingredients. The spot 
for Bamifylline in the sample was confirmed by 
comparing retention factor (Rf) values of the spot 
with that of the standard. 
2.4.2. Sensitivity 
Sensitivity of the method was determined 
with respect to limit of detection (LOD) and limit of 
quantification (LOQ). Noise was determined by 
scanning blank spot (methanol) six times. Series of 
concentrations of drug solutions (5–750 ng/spot) 
were applied on plate and analyzed to determine 
LOD and LOQ. LOD was calculated as 3 times the 
noise level, and LOQ was calculated as 10 times the 
noise level. LOD and LOQ were experimentally 
verified by diluting the known concentrations of 
Bamifylline until the average responses were 
approximately 3–10 times the standard deviation 
(SD) of the responses for six replicate 
determinations.  
2.4.3. Linearity and calibration curves 
Linearity of the method was evaluated by 
constructing calibration curves at six concentration 
levels. Calibration curves were plotted over a 
concentration range of 100 – 600 ng/spot. The 
calibration curves were developed by plotting peak 
area vs. concentrations (n = 6) with the help of the 
win-CATS software.  
2.4.4. Accuracy 
Accuracy of the method was evaluated by 
carrying the recovery study at three levels. Recovery 
experiments were performed by adding three 
different amounts of standard drug, i.e., 80, 100, and 
120% of the drug, to the preanalyzed MME 
formulations, solution and conventional tablets, and 
the resultant was reanalyzed six times. 
2.4.5. Precision 
Precision was evaluated in terms of intra-
day and inter-day precisions. Intra-day precision was 
determined by analyzing sample solutions of 
Bamifylline from formulation at three levels covering 
low, medium, and higher concentrations of 
calibration curve for five times on the same day. 
Inter-day precision was determined by analyzing 
sample solutions of Bamifylline at three levels 
covering low, medium, and higher concentrations 
over a period of seven days (n = 5). The peak areas 
obtained were used to calculate mean and % RSD 
(relative SD) values. 
2.4.6. Repeatability (System precision) 
Repeatability of measurement of peak area 
was determined by analyzing different amount of 
Bamifylline samples covering low, medium, and 
higher ranges of the calibration curve seven times 
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without changing the position of plate. Repeatability 
of sample application was assessed by spotting 
Bamifylline samples covering similar range of 
calibration curve seven times and analyzing them 
once. 
2.4.7. Robustness 
By introducing small changes in mobile 
phase composition, its volume, chamber saturation 
time, and slight change in the solvent migration 
distance, the effects on the results were examined. 
Robustness of the method was determined in 
triplicate at a concentration level of 400 ng/spot and 
the mean and % RSD of peak area was calculated. 
2.5. Application of developed method for Analysis 
of Bamifylline in formulations 
Twenty tablets were weighed and finely 
powdered. Quantity equivalent to 10 mg of drug was 
weighed accurately and dissolved in 50 mL 
methanol. The solution was sonicated for 15 min and 
then filtered through Whatmann filter paper No. 41. 
The residue was washed thoroughly with methanol. 
The filtrate and washings were combined and diluted 
suitably with methanol to obtain a 100 µg/mL 
concentration of Bamifylline. On HPTLC plates, 4 
µL of these solutions were spotted and analyzed for 
Bamifylline content using proposed method as 
described earlier. The possibility of interference from 
other components of the tablet formulation in the 
analysis was studied. 
 
3. Results and discussion 
To develop HPTLC method of analysis for 
Bamifylline for routine analysis, selection of mobile 
phase was carried out on the basis of polarity. A 
solvent system that would give dense and compact 
spots with appropriate and significantly different Rf 
value for DLT was desired. Various solvent systems 
such as acetone-methanol, methanol–chloroform, 
methanol–toluene, toluene–ethyl acetate, hexane–
ethyl acetate, hexane–acetone, Methanol-chloroform-
toluene-ammonia, toluene–acetonitrile, and toluene–
acetonitrile–glacial acetic acid were evaluated in 
different proportions. Among these, the solvent 
system comprising of methanol: toluene (2.5 + 7.5 
v/v) gave good separation of Bamifylline from its 
matrix with an Rf value of 0.51. It was observed that 
chamber saturation time and solvent migration 
distance are crucial in chromatographic separation as 
chamber saturation time of less than 15 min and 
solvent migration distances greater than 70 mm 
resulted diffusion of analyte spot. Therefore, 
methanol: toluene (2.5 + 7.5 v/v) solvent system with 
chamber saturation time of 20 min at 25°C and 
solvent migration distance of 70 mm was used as 
mobile phase. These chromatographic conditions 
produced a well-defined compact spot of Bamifylline 
with optimum migration at Rf = 0.51 ± 0.01 (Figure 
1). It also gave a good resolution of analyte from 
excipients used in formulation. 
Under the experimental conditions 
employed, the lowest amount of drug that could be 
detected was found to be 7.65 ng/spot and the lowest 
amount of drug that could be quantified was found to 
be 23.19 ng/spot, with RSD <5%. 
Specificity is the ability of an analytical 
method to assess unequivocally the analyte in the 
presence of sample matrix (Patel et al. 2012) 
Bamifylline was separated from excipients with an Rf 
of 0.51 ± 0.01. There was no interfering peak at the 
Rf value of Bamifylline from excipients present in 
commercial formulation, thereby confirming 
specificity of method. 
Linearity of an analytical method is its ability, within 
a given range, to obtain test results that are directly, 
or through a mathematical transformation, 
proportional to concentration of analyte. Method was 
found to be linear in a concentration range of 100–
600 ng/spot (n = 6), with respect to peak area. The 
regression data as shown in Table 1 reveal a good 
linear relationship over the concentration range 
studied demonstrating its suitability for analysis. No 
significant difference was observed in the slopes of 
standard curves (ANOVA, p > .05). 
Accuracy of an analytical method is the closeness of 
test results to true value (Patel et al. 2012). It was 
determined by the application of analytical procedure 
to recovery studies, where known amount of standard 
is spiked in preanalyzed samples solutions. Results of 
accuracy studies from excipient matrix were shown 
in Table 2; recovery values demonstrated the 
accuracy of the method in the desired range. 
The precision of an analytical method 
expresses the degree of scatter between a series of 
measurements obtained from multiple sampling of 
the same homogeneous sample under prescribed 
conditions. Intra-day precision refers to the use of 
analytical procedure within a laboratory over a short 
period of time using the same operator with the same 
equipment, whereas inter-day precision involves 
estimation of variations in analysis when a method is 
used within a laboratory on different days, by 
different analysts (Patel et al. 2012). The results 
obtained are shown in Table 3. In all instances, % 
RSD values were less than 5% confirming the 
precision of the method. 
Ten-microliter aliquots of samples 
containing 200, 400, and 600 ng of Bamifylline were 
analyzed according to proposed method. In order to 
control scanner parameters, i.e., repeatability of 
measurement of peak area, one spot was analyzed 
without changing position of plate (n = 7). By 
spotting and analyzing the same amount several times 
(n = 7), precision of automatic spotting device was 
evaluated. %RSD was consistently less than 5% 
(Table 4), which was well below the instrumental 
specifications, ensuring repeatability of developed 
method as well as proper functioning of the HPTLC 
system. 
The low values of % RSD (Table 5) obtained 
after introducing small deliberate changes in the 
developed HPTLC method confirmed the robustness 
of the method (Patel et al. 2012). 
A single spot at Rf = 0.51 was observed in 
the chromatogram of Bamifylline. No interference 
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from the excipients present in the marketed tablet 
formulation was observed. Analysis of Bamifylline 
two different tablets brands showed a drug content of 
99.12 ± 0.34 % and 98.80 ± 0.57 %. The Bamifylline 
content of the marketed formulations was found to be 
within the limits (±5% of the theoretical value) and is 
mentioned in Table 6. The low %RSD value indicated 
the suitability of this method for routine analysis of 
Bamifylline in various formulations. 
 
4. Conclusion 
A new HPTLC method has been developed 
for the identification and quantification of 
Bamifylline. Low cost of ingredients, faster speed, 
and satisfactory precision and accuracy are the main 
features of this method. Method was successfully 
validated as per ICH guidelines and statistical 
analysis proves that method is sensitive, specific, and 
repeatable. It can be conveniently employed for 
routine quality control analysis of Bamifylline as 
bulk drug in marketed tablets. 
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Table 1. Linear Regression Data for the Calibration Curves (n = 6) 
Range (ng/spot) r2 ± SD Slope ± SD Intercept ± SD 
100 - 600 0.9995 ± 0.001 9.25 ± 1.13 4128.60 ± 64.41 
 
Table 2. Recovery Study. 
Formulation Amount of Drug 
Analyzed (ng) 
Amount of Drug 
Added (ng) 
Theoretical 
Concentration 
(ng) 
% Recovery ± 
SD  
Marketted 250 200 450 99.31 ± 1.45 
Tablets 250 250 500 99.52 ± 0.59 
 250 300 550 99.25 ± 0.61 
     
Table 3 Intra and Inter-Precision Studies (n = 5) 
Amount of Drug 
Spotted (ng) 
Amount of Drug Detected 
(ng, mean ± SD) 
% RSD 
Intra-day (n = 5)   
200 196.58 ± 3.84 0.64 
400 401.12 ± 2.79 0.50 
600 596.26 ± 4.12 0.53 
Inter-day (n = 5)   
200 193.55 ± 5.44 1.06 
400 397.66 ± 2.05 1.05
600 596.26 ± 3.33 1.25 
Table 4 Repeatability Studies (n = 7) 
Parameters Amount of Drug Detected (ng, mean ± SD) 
Amount of Bamifylline Spotted (ng) 200 400 600 
Measurement of peak areaa  199.03 ±21.23 398.16 ± 4.17 589.13 ± 5.05 
%RSD 1.76 2.38 2.31 
Sample application and derivatization 
techniqueb 
200.23 ± 3.41 401.18 ± 3.67  595.88 ± 5.02 
%RSD 2.11 3.00 4.26 
aOne spot is scanned eight times.;   bEight spots scanned once. 
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Table 5 Robustness of Method (n = 3) 
Parameters Amount of 
Bamifylline 
Spotted (ng) 
Amount of Bamifylline 
Detected (ng, mean ± SD) 
%RSD 
Mobile phase composition: 3:7 300 298.11 ± 4.21 2.17 
Mobile phase composition: 2:8 300 299.23 ± 2.39 2.29 
Mobile phase composition: 2.5:7.5 300 299.81 ± 0.56 1.03 
Mobile phase volume: 8 mL 300 301.14 ± 5.77 1.39 
Mobile phase volume: 12 mL 300 298.32 ± 3.76 1.49 
Mobile phase volume: 10 mL 300 200.45 ± 0.78 0.87 
Chamber saturation time: 15 min 300 295.63 ± 3.86 2.57 
Chamber saturation time: 25 min 300 297.49 ± 3.19 2.17 
Chamber saturation time: 20 min 300 299.77 ± 1.14 0.58 
Solvent migration distance: 68 mm 300 302.57 ± 3.16 1.79 
Solvent migration distance: 72 mm 300 303.14 ± 5.97 1.99 
Solvent migration distance: 70 mm 300 301.02 ± 1.22 1.32 
 
Table 6 Content of Bamifylline in Formulation 
Formulation Actual 
Concentration 
ng/spot 
% Bamifylline % RSD 
Tablets Brand -1 300 99.12 ± 0.34 1.26 
Tablets Brand -2 300 98.80 ± 0.57 2.01 
 
Figure. 1 Chromatogram of standard Bamifylline (300 ng/spot) using mobile phase methanol: toluene 
(2.5 + 7.5 v/v). 
 
 
 
 
 
 
 
